STEVE ASELAGE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STEVE ASELAGE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEVE ASELAGE. STEVE ASELAGE is a Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and a EVP, Global Commercial Ops in CTI BIOPHARMA CORP ($CTIC) and a in Acer Therapeutics Inc. ($OPXA) and a Director in Acer Therapeutics Inc. ($OPXA) and an Chief Executive Officer in Retrophin, Inc. ($RTRX) and a Director in Retrophin, Inc. ($RTRX).
Address: 501 ELLIOTT AVE W. SUITE 400 SEATTLE 98119 WA
Companies in which STEVE ASELAGE is an Insider
Acer Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEVE ASELAGE: Director
Holdings: 63,905 shares
Current Value: $65,183
Latest Transaction: Jan 20 2021
$ACER Market Capitalization: $7.21M
$ACER Previous Close: $1.02
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIOCRYST PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of STEVE ASELAGE: Director
Holdings: 31,496 shares
Current Value: $178,582
Latest Transaction: Mar 02 2021
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CTI BIOPHARMA CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEVE ASELAGE: EVP, Global Commercial Ops
Holdings: 6,000 shares
Current Value: $28,020
Latest Transaction: Feb 20 2004
$CTIC Market Capitalization: $129.36M
$CTIC Previous Close: $4.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Travere Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEVE ASELAGE: Director, Chief Executive Officer
Holdings: 198,940 shares
Current Value: $3,992,726
Latest Transaction: Apr 20 2021
$RTRX Market Capitalization: $766.34M
$RTRX Previous Close: $20.07
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of STEVE ASELAGE
Sentiment: All, ACER, BCRX, CTIC, RTRX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 20 2021 | RTRX | Travere Therapeuti ... | ASELAGE STEVE | Director | Option Exercise | M | 16.23 | 10,000 | 162,300 | 140,000 | |
| Apr 20 2021 | RTRX | Travere Therapeuti ... | ASELAGE STEVE | Director | Sell | S | 26.23 | 10,000 | 262,300 | 188,940 | 198.9 K to 188.9 K (-5.03 %) |
| Apr 20 2021 | RTRX | Travere Therapeuti ... | ASELAGE STEVE | Director | Buy | M | 16.23 | 10,000 | 162,300 | 198,940 | 188.9 K to 198.9 K (+5.29 %) |
| Mar 19 2021 | RTRX | Travere Therapeuti ... | ASELAGE STEVE | Director | Option Exercise | M | 16.23 | 10,000 | 162,300 | 150,000 | |
| Mar 19 2021 | RTRX | Travere Therapeuti ... | ASELAGE STEVE | Director | Sell | S | 27.56 | 7,727 | 212,956 | 188,940 | 196.7 K to 188.9 K (-3.93 %) |
| Mar 19 2021 | RTRX | Travere Therapeuti ... | ASELAGE STEVE | Director | Sell | S | 27.35 | 10,000 | 273,500 | 196,667 | 206.7 K to 196.7 K (-4.84 %) |
| Mar 19 2021 | RTRX | Travere Therapeuti ... | ASELAGE STEVE | Director | Buy | M | 16.23 | 10,000 | 162,300 | 206,667 | 196.7 K to 206.7 K (+5.08 %) |